It was reported that Germany opposed the US administration’s proposal to abolish intellectual property rights on Covid-19 vaccines.
“Intellectual property protection is a source of innovation and should remain so in the future,” said Chancellor Angela Merkel’s spokesperson.
Emphasizing that the limiting factor in vaccine production is not patents, but production and high quality standards, the spokesperson said, “We, as Germany, make an intense effort to increase vaccine production capacity in the European Union and in the world.
WHITE PALACE: THE SUBJECT IS ON THE AGENDA
White House Spokesperson Jen Psaki stated at the press conference yesterday that the removal of intellectual property rights on Covid-19 vaccines is on the agenda, but no decision has been made on this issue.
US Trade Representative Katherine Tai also stated that they support the abolition of intellectual property in order to increase the production capacity of Covid-19 vaccines and that they will participate in the necessary negotiations in the WTO.
While the idea of the abolition of intellectual property right is supported by the poor and some developing countries, it is also noteworthy that the number of companies and researchers opposing the plan is quite high in rich Western countries.
UĞUR ŞAHİN: WAIVER IS NOT CORRECT
Meanwhile, one of the founders of the German pharmaceutical company BioNTech, Prof. Dr. Uğur Şahin stated that it is not the right way to give up intellectual property in order to increase the production capacity of Covid-19 vaccines, instead, production licenses should be given.